Radiopharmaceuticals Researching Radiosensitizers, a New Class of Drugs That Would Make Tumors More Vulnerable to Radiation Therapy By Staff Reports 5 years ago Two out of three cancer patients are treated with radiation, but the therapy often fails
Pharmaceutical Business News Radiopharmaceuticals Q BioMed Gears up for Production of Cancer Pain Palliation Drug with Commercial Launch Expected in Q2 2017 By Staff Reports 5 years ago Q BioMed Inc, a NYC-based biomedical acceleration and development company has begun process validation for
cancer Cell Therapy Radiopharmaceuticals Antibody Drug Conjugates May Help Personalize Radiotherapy For Patients With Cancer By Staff Reports 5 years ago Many types of cancer become drug resistant, making them difficult to treat. Researchers with University
Biotechnology cancer Clinical Trials Radiopharmaceuticals FDA Greenlights Orphan Drug Status for Radioimmuneconjugate for Treating Refractory and Relapsed Acute Myeloid Leukemia in Elderly Patients By Staff Reports 6 years ago The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Iomab-B, a
Radiopharmaceuticals rare diseases Pharma Company Funds Saint Louis University Researcher’s Quest to Treat His Daughter’s Disease By Staff Reports 6 years ago A team of Saint Louis University scientists led by Fran Sverdrup, Ph.D., developing a treatment